296 related articles for article (PubMed ID: 33320197)
1. Reproductive performance of women with and without intrauterine adhesions following recurrent dilatation and curettage for miscarriage: long-term follow-up of a randomized controlled trial.
Hooker AB; de Leeuw RA; Twisk JWR; Brölmann HAM; Huirne JAF
Hum Reprod; 2021 Jan; 36(1):70-81. PubMed ID: 33320197
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and neonatal outcomes 42 months after application of hyaluronic acid gel following dilation and curettage for miscarriage in women who have experienced at least one previous curettage: follow-up of a randomized controlled trial.
Hooker AB; de Leeuw RA; Twisk JWR; Brölmann HAM; Huirne JAF
Fertil Steril; 2020 Sep; 114(3):601-609. PubMed ID: 32660725
[TBL] [Abstract][Full Text] [Related]
3. Reproductive performance after the application of hyaluronic acid gel after dilation and curettage in women who have experienced at least one previous curettage: long-term results of a multicenter prospective randomized trial.
Hooker AB; de Leeuw RA; van de Ven PM; Brölmann HAM; Huirne JAF
Fertil Steril; 2018 Dec; 110(7):1231-1238. PubMed ID: 30503111
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: short-term outcomes of a multicenter, prospective randomized controlled trial.
Hooker AB; de Leeuw R; van de Ven PM; Bakkum EA; Thurkow AL; Vogel NEA; van Vliet HAAM; Bongers MY; Emanuel MH; Verdonkschot AEM; Brölmann HAM; Huirne JAF
Fertil Steril; 2017 May; 107(5):1223-1231.e3. PubMed ID: 28390688
[TBL] [Abstract][Full Text] [Related]
5. New Crosslinked Hyaluronan Gel for the Prevention of Intrauterine Adhesions after Dilation and Curettage in Patients with Delayed Miscarriage: A Prospective, Multicenter, Randomized, Controlled Trial.
Li X; Wu L; Zhou Y; Fan X; Huang J; Wu J; Yu R; Lou J; Yang M; Yao Z; Xue M
J Minim Invasive Gynecol; 2019 Jan; 26(1):94-99. PubMed ID: 29678756
[TBL] [Abstract][Full Text] [Related]
6. Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome.
Deans R; Vancaillie T; Ledger W; Liu J; Abbott JA
Hum Reprod; 2018 Oct; 33(10):1847-1853. PubMed ID: 30239778
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome.
Hooker AB; Lemmers M; Thurkow AL; Heymans MW; Opmeer BC; Brölmann HA; Mol BW; Huirne JA
Hum Reprod Update; 2014; 20(2):262-78. PubMed ID: 24082042
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine administration of G-CSF for promoting endometrial growth after hysteroscopic adhesiolysis: a randomized controlled trial.
Zhang Y; Chen X; Chen S; Wei C; Li B; Wang Z; Shen X; Lin X
Hum Reprod; 2022 Apr; 37(4):725-733. PubMed ID: 35147195
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. The density of endometrial glandular openings: a novel variable to predict the live birth rate in patients with intrauterine adhesions following hysteroscopic adhesiolysis.
Zhao X; Gao B; Yang X; Zhang A; Jamail G; Li Y; Xu D
Hum Reprod; 2021 Mar; 36(4):965-975. PubMed ID: 33486509
[TBL] [Abstract][Full Text] [Related]
11. Reproductive outcomes in women with mild intrauterine adhesions; a systematic review and meta-analysis.
Hooker AB; Mansvelder FJ; Elbers RG; Frijmersum Z
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6933-6941. PubMed ID: 34044740
[TBL] [Abstract][Full Text] [Related]
12. Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility.
Bosteels J; Weyers S; D'Hooghe TM; Torrance H; Broekmans FJ; Chua SJ; Mol BWJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011110. PubMed ID: 29178172
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a New Crosslinked Hyaluronan Gel in the Prevention of Intrauterine Adhesions.
Can S; Kirpinar G; Dural O; Karamustafaoglu BB; Tas IS; Yasa C; Ugurlucan FG
JSLS; 2018; 22(4):. PubMed ID: 30524185
[TBL] [Abstract][Full Text] [Related]
14. Influence of auto-cross-linked hyaluronic acid gel on pregnancy rate and hysteroscopic outcomes following surgical removal of intra-uterine adhesions.
Thubert T; Dussaux C; Demoulin G; Rivain AL; Trichot C; Deffieux X
Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():65-9. PubMed ID: 26246163
[TBL] [Abstract][Full Text] [Related]
15. Anti-adhesion Gel versus No gel following Operative Hysteroscopy prior to Subsequent fertility Treatment or timed InterCourse (AGNOHSTIC), a randomised controlled trial: protocol.
van Wessel S; Hamerlynck T; Schutyser V; Tomassetti C; Wyns C; Nisolle M; Verguts J; Colman R; Weyers S; Bosteels J
Hum Reprod Open; 2021; 2021(1):hoab001. PubMed ID: 33623830
[TBL] [Abstract][Full Text] [Related]
16. Does hyaluronic acid gel reduce intrauterine adhesions after dilation and curettage in women with miscarriage? A Multicentric randomized controlled trial (HYFACO Study).
Sroussi J; Bourret A; Pourcelot AG; Thubert T; Lesavre M; Legendre G; Tuffet S; Rousseau A; Benifla JL;
Am J Obstet Gynecol; 2022 Oct; 227(4):597.e1-597.e8. PubMed ID: 35667420
[TBL] [Abstract][Full Text] [Related]
17. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review.
Hooker AB; Aydin H; Brölmann HA; Huirne JA
Fertil Steril; 2016 Jan; 105(1):156-64.e1-2. PubMed ID: 26453977
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.
Bordewijk EM; Jannink TI; Weiss NS; de Vries T; Nahuis M; Hoek A; Goddijn M; Mol BW; van Wely M;
Hum Reprod; 2023 Mar; 38(3):421-429. PubMed ID: 36622200
[TBL] [Abstract][Full Text] [Related]
19. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
[TBL] [Abstract][Full Text] [Related]
20. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
